1. Home
  2. Apply for funding
  3. Closed calls

Closed calls

The following Calls for proposals are now closed for proposals from applicant consortia. The resulting projects have been launched or are under development.

 

IMI2
  • IMI2 - Call 16
    Launched on 18 July 2018
    Topics on antimicrobial resistance
  • IMI2 - Call 15
    Launched on 18 July 2018
    Topics on integrated research platforms, digital clinical trials, immune-mediated diseases, medicines safety, brain disorders, blockchain, antimicrobial resistance
  • IMI2 - Call 14
    Launched on 15 March 2018
    Topics on immune diseases, imaging, machine learning, decentralised clinical trials
  • IMI2 - Call 13
    Launched on 30 November 2017
    Topics on heart disease, inflammatory skin disease, antimicrobial resistance, neurodegenerative diseases, stem cells, mobility, cancer, toxicology, medicines safety, repurposing
  • IMI2 - Call 12
    Launched on 19 July 2017
    Topics on Alzheimer's disease, data, primary Sjögren’s Syndrome, vaccines, blood-brain barrier, European screening centre
  • IMI2 - Call 11
    Launched on 19 July 2017
    Topic on the exploitation of IMI project results
  • IMI2 - Call 10 
    Launched 21 December 2016
    Topics on hypoglycaemia, big data and prostate cancer, pain, paediatric clinical trials, biomanufacturing, soluter carrier genes, patient perspectives, autism spectrum disorders

  • IMI2 - Call 9 
    Launched 27 April 2016
    Topics on antimicrobial resistance, rheumatic diseases, data quality, medicines safety, liver disease, vaccines

  • IMI2 - Call 8
    Launched 18 December 2015
    Topic on Ebola and related diseases

  • IMI2 - Call 7 
    Launched 18 December 2015
    Topics on medicines safety, Alzheimer's and Parkinson's diseases, pain, eye diseases, paediatric cancers, big data, heart disease and big data

  • IMI2 - Call 6 

    Launched 6 October 2015
    Topics on medicines safety, infectious disease, big data and Alzheimer’s disease, big data and blood cancers

  • IMI2 - Call 5 
    Launched 9 July 2015
    Topics on benefits/risks, diabetes, dementia, patient engagement

  • IMI2 - Call 4 

    Launched 17 December 2014
    Topic on medicines adaptive pathways to patients (MAPPs)

  • IMI2 - Call 3 

    Launched 17 December 2014
    Topics on remote assessment of disease, diabetes, neuropsychiatry, vaccines, knowledge management

  • IMI2 - Call 2 
    Launched 6 November 2014
    Topics on Ebola and related diseases

  • IMI2 - Call 1 
    Launched 9 July 2014
    Topics on diabetes and eye diseases

 

IMI1

  • IMI1 - Call 11 
    Launched 11 December 2013
    Topics on osteoarthritis, dementia, cancer, infectious disease, drug discovery, antimicrobial resistance, environmental impacts

  • IMI1 - Call 10 
    Launched 29 October 2013
    Topic on vaccines

  • IMI1 - Call 9 
    Launched 9 July 2013
    Topics on pharmacovigilance, geriatric diseases, antimicrobial resistance

  • IMI1 - Call 8 
    Launched 17 December 2012
    Topics on antimicrobial resistance, stem cells, immune disorders, neurodegenerative disorders

  • IMI1 - Call 7 
    Launched 17 July 2012
    Topics on vaccines and real world data

  • IMI1 - Call 6 
    Launched 24 May 2012
    Topics on antimicrobial resistance

  • IMI1 - Call 5 
    Launched 6 March 2012
    Topics on European screening centre and joint compound collection

  • IMI1 - Call 4 
    Launched 18 July 2011
    Topics on knowledge management, diabetes, dementia, drug delivery, sustainable chemistry, stem cells, drug discovery

  • IMI1 - Call 3 

    Launched 22 October 2010
    Topics on medicines safety, vaccines, tuberculosis, autism spectrum disorders, diabetes, patient education

  • IMI1 - Call 2 
    Launched 27 November 2009
    Topics on efficacy, cancer, infectious disease, immune disorders, knowledge management

  • IMI1 - Call 1 
    Launched 30 April 2008
    Topics on medicines safety, efficacy, benefit/risk, diabetes, pain, brain disorders, respiratory disease, education and training